Methimazole

Verify with FDA CVM →

1,035 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
1,035
Total Reports
146
Deaths Reported
1410.0%
Death Rate

Active Ingredients

Methimazole

Administration Routes

UnknownOralTopicalTransdermalOtherAuricular (Otic)IntradermalIntratumor

Species Affected

Cat 1,017
Unknown 16
Dog 2

Most Affected Breeds

Domestic Shorthair 685
Domestic Longhair 96
Domestic Mediumhair 55
Cat (unknown) 46
Domestic (unspecified) 36
Siamese 30
Maine Coon 24
Unknown 17
Cat (other) 15
Persian 4

Most Reported Reactions

Vomiting 173
Weight loss 106
Anorexia 97
Lack of efficacy - NOS 93
Lethargy (see also Central nervous system depression in 'Neurological') 88
Not eating 86
Lethargy (see also Central nervous system depression in Neurological) 84
Death by euthanasia 82
Ataxia 69
Diarrhoea 68
Behavioural disorder NOS 59
Decreased appetite 58

Outcome Breakdown

Ongoing
382 (38.4%)
Outcome Unknown
233 (23.4%)
Recovered/Normal
218 (21.9%)
Euthanized
83 (8.4%)
Died
63 (6.3%)
Recovered with Sequela
15 (1.5%)

Data Summary

Metric Value
Total adverse event reports 1,035
Reports involving death 146
Case-fatality rate (reported events) 1410.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Methimazole Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 1,035 adverse event reports referencing Methimazole, including 146 reports in which the animal died — a 1410.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Methimazole. Reported administration routes include Unknown, Oral, Topical, Transdermal. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Methimazole reports are Cat (1,017 reports), Unknown (16 reports), Dog (2 reports), with Cat accounting for the largest share. Within those species, Domestic Shorthair (685), Domestic Longhair (96), Domestic Mediumhair (55) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Methimazole are Vomiting (173), Weight loss (106), Anorexia (97), Lack of efficacy - NOS (93). Of the 994 reports with a coded outcome, Ongoing is the leading category at 38.4%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Methimazole.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial